Return On Equity ratio Analysis of AcelRx Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY ROE
Period Ending - Dec-23
Very Poor ROE
-151.46
Period Ending - Dec-22
Excellent ROE
218.92
Growth
-169.19 %
Trailing Twelve Months ROE
Period Ending - Dec-23
Very Poor ROE
-46.58
Most recent Quarter ROE
Period Ending - Dec-23
Very Poor ROE
-32.02
ROE Analysis of AcelRx Pharmaceuticals Inc
| ROE Ratio of AcelRx Pharmaceuticals Inc with value of -46.58 means is not able to effectively utilize its Shareholders Fund in order to generate a profit in trailing twelve months. |
| ROE Ratio of AcelRx Pharmaceuticals Inc with value of -32.02 means is not able to effectively utilize its Shareholders Fund in order to generate a profit in latest Quarter ending on Dec-23. |
| ROE Ratio of ACRX drastically fell by -169.19 % this year. |
| ROE Ratio with value of 218.92 was highest in Year Dec-22 in last Five Years. |
| ROE Ratio with value of -151.46 was lowest in Year Dec-23 in last Five Years. |
| Latest ROE Ratio with value of -151.46 is lower than Average ROE of 13.49 in last five years. |
| ROE of AcelRx Pharmaceuticals Inc is negative because of poor net profit in last Financial Year , last Quarter and also in last twelve Months. |
Other ROE Related Info of ACRX that may interest you.
AcelRx Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ACRX | 0.8945 | 0.86 | 4.01 % | Drug Manufacturers-Specialty & Generic |
Defination of Return On Equity
The Return on Equity (ROE) is a profitability metric that measures a company's ability to generate profits using its shareholder's fund. ROE is calculated by dividing Net Income by Shareholders' Fund. more ..
ROE Related Ratios
| ReturnOnAsset | NetProfitMargin |
Tsr Profitability Index
| Poor Profitability Stock | |
FY - Historical Return On Equity of AcelRx Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| ROE | -151.46 | 218.92 | 0 | 0 | 0 | -1108.61 | 0 |
| Change | -169.19 % | 0 % |
FY Chart of Return On Equity of AcelRx Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)